Pure small cell carcinoma of the prostate is a rare and aggressive neoplasm, with only few cases described in literature and poor prognosis: mean survival is 5 months. We report the case of a patient with this disease, with special attention to the evolution of neuroendocrine markers as Chromogranine A and neuron-specific enolase during the progression of the tumor, evaluating their possible role in staging and follow up
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Primary small cell carcinoma of the prostate (SCPCa) is a rare pathologic entity with unique clinica...
*Author for Correspondence Pure small cell carcinoma of the prostate is a rare and aggressive neopla...
Within the framework of the Rare Cancer Network Study, we examined 30 patients suffering from small ...
Within the framework of the Rare Cancer Network Study, we examined 30 patients suffering from small ...
An 82-year-old man, who 7 years previously had been treated for adenocarcinoma of the prostate, was ...
Neuroendocrine carcinoma of the prostate belongs to the so-called small-cell neuroendocrine carcinom...
Most prostate cancers (90%) are acinar adenocarcinomas originating in the peripheral or other prosta...
Most prostate cancers (90%) are acinar adenocarcinomas originating in the peripheral or other prosta...
Small cell carcinoma(SCC) of prostate is a very rare and highly aggressive neoplasm which constitut...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Primary small cell carcinoma of the prostate (SCPCa) is a rare pathologic entity with unique clinica...
*Author for Correspondence Pure small cell carcinoma of the prostate is a rare and aggressive neopla...
Within the framework of the Rare Cancer Network Study, we examined 30 patients suffering from small ...
Within the framework of the Rare Cancer Network Study, we examined 30 patients suffering from small ...
An 82-year-old man, who 7 years previously had been treated for adenocarcinoma of the prostate, was ...
Neuroendocrine carcinoma of the prostate belongs to the so-called small-cell neuroendocrine carcinom...
Most prostate cancers (90%) are acinar adenocarcinomas originating in the peripheral or other prosta...
Most prostate cancers (90%) are acinar adenocarcinomas originating in the peripheral or other prosta...
Small cell carcinoma(SCC) of prostate is a very rare and highly aggressive neoplasm which constitut...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
Prostate cancer is among the most common malignancies in males in the United States and adenocarcino...
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Small cell carcinoma of the prostate (PSCC) is a rare and highly aggressive malignancy with a dismal...
Primary small cell carcinoma of the prostate (SCPCa) is a rare pathologic entity with unique clinica...